HOME > Detail View

Detail View

Drug treatment of sleep disorders [electronic resource]

Drug treatment of sleep disorders [electronic resource]

Material type
E-Book(소장)
Personal Author
Guglietta, Antonio.
Title Statement
Drug treatment of sleep disorders [electronic resource] / Antonio Guglietta, editor.
Publication, Distribution, etc
Cham :   Springer International Publishing :   Imprint: Springer,   2015.  
Physical Medium
1 online resource (viii, 297 p.) : ill. (some col.).
Series Statement
Milestones in drug therapy,2296-6056
ISBN
9783319115146
요약
Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.
General Note
Title from e-Book title page.  
Content Notes
An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
Bibliography, Etc. Note
Includes bibliographical references and index.
이용가능한 다른형태자료
Issued also as a book.  
Subject Added Entry-Topical Term
Medicine. Sleep disorders --Chemotherapy.
Short cut
URL
000 00000nam u2200205 a 4500
001 000046035081
005 20200710155146
006 m d
007 cr
008 200702s2015 sz a ob 001 0 eng d
020 ▼a 9783319115146
040 ▼a 211009 ▼c 211009 ▼d 211009
050 4 ▼a RC547
082 0 4 ▼a 616.8/498061 ▼2 23
084 ▼a 616.8498061 ▼2 DDCK
090 ▼a 616.8498061
245 0 0 ▼a Drug treatment of sleep disorders ▼h [electronic resource] / ▼c Antonio Guglietta, editor.
260 ▼a Cham : ▼b Springer International Publishing : ▼b Imprint: Springer, ▼c 2015.
300 ▼a 1 online resource (viii, 297 p.) : ▼b ill. (some col.).
490 1 ▼a Milestones in drug therapy, ▼x 2296-6056
500 ▼a Title from e-Book title page.
504 ▼a Includes bibliographical references and index.
505 0 ▼a An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
520 ▼a Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.
530 ▼a Issued also as a book.
538 ▼a Mode of access: World Wide Web.
650 0 ▼a Medicine.
650 0 ▼a Sleep disorders ▼x Chemotherapy.
700 1 ▼a Guglietta, Antonio.
830 0 ▼a Milestones in drug therapy.
856 4 0 ▼u https://oca.korea.ac.kr/link.n2s?url=http://dx.doi.org/10.1007/978-3-319-11514-6
945 ▼a KLPA
991 ▼a E-Book(소장)

Holdings Information

No. Location Call Number Accession No. Availability Due Date Make a Reservation Service
No. 1 Location Main Library/e-Book Collection/ Call Number CR 616.8498061 Accession No. E14026160 Availability Loan can not(reference room) Due Date Make a Reservation Service M

New Arrivals Books in Related Fields

대한배뇨장애요실금학회 (2021)
Amin, Mahul B. (2021)
Louis, Elan D (2022)
Church, Dawson (2020)